Fresenius SE & Co. KGaA Stock Other OTC
Equities
FSNUY
US35804M1053
Healthcare Facilities & Services
Sales 2024 * | 22.96B 24.5B 33.73B | Sales 2025 * | 24.06B 25.68B 35.35B | Capitalization | 15.75B 16.81B 23.14B |
---|---|---|---|---|---|
Net income 2024 * | 1.45B 1.55B 2.13B | Net income 2025 * | 1.78B 1.9B 2.62B | EV / Sales 2024 * | 1.31 x |
Net Debt 2024 * | 14.27B 15.23B 20.97B | Net Debt 2025 * | 13.48B 14.39B 19.8B | EV / Sales 2025 * | 1.22 x |
P/E ratio 2024 * |
10.7
x | P/E ratio 2025 * |
8.78
x | Employees | - |
Yield 2024 * |
3.34% | Yield 2025 * |
3.79% | Free-Float | 73.04% |
Latest transcript on Fresenius SE & Co. KGaA
Managers | Title | Age | Since |
---|---|---|---|
Michael Sen
CEO | Chief Executive Officer | 55 | 21-04-11 |
Sara Hennicken
DFI | Director of Finance/CFO | 44 | 18-12-31 |
Michael Moser
CMP | Compliance Officer | - | 23-07-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Diekmann
BRD | Director/Board Member | 69 | 15-05-19 |
Wolfgang Kirsch
CHM | Chairman | 69 | 19-12-31 |
Director/Board Member | 63 | 16-05-12 |
1st Jan change | Capi. | |
---|---|---|
-14.25% | 85.35B | |
+14.46% | 81.95B | |
+9.37% | 28.99B | |
-11.40% | 16.98B | |
+0.22% | 15.35B | |
+4.32% | 12.42B | |
-2.34% | 11.88B | |
+32.69% | 12.19B | |
-31.40% | 11.89B |